Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement for the markup of H.R. 2374, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (Stop STALLING Act): “H.R. 2374, the ‘Stop STALLING Act,’ takes an important step toward lowering drug prices and increasing competition in health care ... Read more »

Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement for the markup of H.R. 2376, the Prescription Pricing for the People Act of 2019: “H.R. 2376, the ‘Prescription Pricing for the People Act of 2019,’ would require the Federal Trade Commission to conduct a comprehensive report on the state of competition in the drug supply cha... Read more »

Washington, D.C. – Today, the House Judiciary Committee unanimously passed four bills to address prescription drug pricing, including H.R. 965, the CREATES Act; H.R. 2375, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 2374, the Stop STALLING Act; and H.R. 2376, the Prescription Pricing for the People Act of 2019. This markup is part of the first phase of the Committee’s agen... Read more »

Washington, D.C. — Reps. Jerrold Nadler (D-N.Y.), Chairman of the House Judiciary Committee and Doug Collins (R-Ga.), Ranking Member of the House Judiciary Committee, today introduced the Prescription Pricing for the People Act of 2019. The legislation requires the Federal Trade Commission (FTC) to study pharmacy benefits managers (PBMs) and how their actions are affecting patients and local pharm... Read more »

Washington, D.C. – Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) and Ranking Member Doug Collins (R-GA) introduced H.R. 2375, the bipartisan Preserve Access to Affordable Generics and Biosimilars Act. This legislation strengthens the Federal Trade Commission’s (FTC) ability to challenge settlement agreements between large brand drug companies and generic drug companies in court, ... Read more »

Washington, D.C. – Five House Committee Chairs sent letters to the Department of Justice (DOJ), the Department of Health and Human Services (HHS), and the White House requesting documents and information regarding the involvement of White House officials in the Administration’s troubling decision to not defend the constitutionality of the Affordable Care Act (ACA). The letters were signed by Comm... Read more »

Washington, D.C. – Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during a Subcommittee on Antitrust, Commercial, and Administrative Law hearing on “Diagnosing the Problem: Exploring the Effects of Consolidation and Anticompetitive Conduct in Health Care Markets”: “The Judiciary Committee has a strong tradition of bipartisan efforts to promo... Read more »

WASHINGTON, D.C. -- Today, 9/11 first responders, survivors, and their families joined with Jon Stewart, Representatives Jerrold Nadler (D-NY), Carolyn B. Maloney (D-NY), and Peter King (R-NY) and Senators Kirsten Gillibrand (D-NY) and Cory Gardner (R-CO), Senate Minority Leader Chuck Schumer to introduce the bipartisan Never Forget the Heroes: Permanent Authorization of the September 11th Victim ... Read more »

WASHINGTON, D.C. -- Today, Representatives Jerrold Nadler (D-NY), Carolyn B. Maloney (D-NY), and Peter King (R-NY), sponsors of the James Zadroga 9/11 Health and Compensation Act, released the following statement following the announcement that the September 11th Victim Compensation Fund will need to make severe cuts to compensation awards due to a budget shortfall: “This is devastating news to th... Read more »

WASHINGTON, D.C. -- Today, Representatives Jerrold Nadler (D-NY), Carolyn B. Maloney (D-NY), and Peter King (R-NY), the original cosponsors of the Zadroga Act, announced that they have asked Congressmen Max Rose (D-NY) and Lee Zeldin (R-NY) to work on a bipartisan effort to educate members elected after the passage of the James Zadroga 9/11 Health and Compensation Reauthorization Act in 2015 on th... Read more »